Skip to main content
Premium Trial:

Request an Annual Quote

Gordon Brandt, Steven Quay

Premium
Nastech Pharmaceutical has promoted Gordon Brandt to the position of president. He was formerly executive vice president of clinical research and medical affairs.
 
In his new role, Brandt takes over for former President Steven Quay, who will continue to serve as Nastech’s chairman and CEO.
 
"This move … allows me to increase my efforts on establishing [spinout] MDRNA as an independent company concentrating on the development of RNA-based therapeutics, which we believe will eventually provide greater focus for both companies,” Quay said in a statement.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.